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ABSTRACT 
Patients with kidney failure usually undergo hemodialysis, a process by which toxins produced by the body are 
filtered from the blood, in order to survive. The preferred form for vascular access is called an 
arteriovenousfistula (AVF), a surgically created connection between an artery and vein that is utilized to undergo 
dialysis. However, AVFs have a failure rate of 50-60%. One of the contributions to AVF failure is endothelial cell 
dysfunction and loss of glycocalyx, which allows neutrophils and other native cells into the media of the vessel, 
which causes an inflammatory response. Our lab addresses endothelial dysfunction by mimicking the function of 
the glycocalyx to prevent transmigration of inflammatory cells and ultimately create a healthier vessel for 
hemodialysis. We have synthesized several glycocalyx mimics consisting of a dermatan sulfate backbone with 
multiple selectin and ICAM-binding peptides attached. Initial testing involved determining the ability of the 
variants to bind to inflamed endothelial cells. We also cultured human promyelocytic leukemia cells (HL60) and 
used retinoic acid to differentiate them into neutrophils. These cells would then test the glycocalyx mimics ability 
to prevent migration of neutrophils. Thus far, we have seen that the glycocalyx mimics binding to endothelial 
cells and that this binding is dependent upon the type of selectin and/or ICAM-binding peptides as well as how 
many peptides are present per dermatan sulfate backbone. We have also shown that proliferation occurs 10 
days after seeding, and that rentinoic acid (RA) differentiates HL60 cells into neutrophils. We have developed a 
protocol for differentiation of HL60 cells to neutrophils, a promising set of glycocalyx mimics, and culturing 
method for HL60 cells. 
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